Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes hCA IX/XII and the angiogenic receptor VEGFR-2. It demonstrates VEGFR-2 inhibition with an IC50 of 204 nM and
Molecular Weight:
498.55
Formula:
C23H26N6O5S
* VAT and and shipping costs not included. Errors and price changes excepted
